Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer

被引：0
|
作者：
Yu, Ke-Da [1 ]
Zhou, Zhi-Rui [1 ]
Shao, Zhi-Ming [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-14-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-14-04
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study
    Gligorov, Joseph
    Pivot, Xavier
    Ataseven, Beyhan
    De Laurentiis, Michelino
    Jung, Kyung Hae
    Manikhas, Alexey
    Azim, Hamdy Abdel
    Gupta, Kushagra
    Alexandrou, Ari
    Herraez-Baranda, Luis
    Tosti, Nadia
    Restuccia, Eleonora
    BREAST, 2022, 64 : 151 - 158
  • [12] Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients
    Fang, Yan
    Wang, Zheng
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    JOURNAL OF CANCER, 2020, 11 (09): : 2602 - 2609
  • [13] Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer
    Printz, Carrie
    CANCER, 2019, 125 (08) : 1213 - 1213
  • [14] Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
    Sotelo, Miguel J.
    Angel Garcia-Saenz, Jose
    Manso, Luis
    Moreno, Fernando
    Ciruelos, Eva
    Callata, Hector R.
    Mendiola, Cesar
    Cabezas, Santiago
    Ghanem, Ismael
    Diaz-Rubio, Eduardo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 967 - 972
  • [15] Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Spector, Neil L.
    Blackwell, Kimberly L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5838 - 5847
  • [16] Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Yeo, Winnie
    Luk, M. Y.
    Soong, Inda S.
    Yuen, Tony Y. S.
    Ng, T. Y.
    Mo, Frankie K. F.
    Chan, K.
    Wong, S. Y.
    Tsang, Janice
    Leung, Carmen
    Suen, Joyce J. S.
    Ngan, Roger K. C.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 56 - 62
  • [17] Short-duration adjuvant trastuzumab therapy in human epidermal growth factor receptor 2-positive breast cancers: Has its time come?
    Gogia, Ajay
    Mittal, Abhenil
    Sharma, Atul
    Sagiraju, Hari Krishna Raju
    NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (02): : 90 - 91
  • [18] Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
    Piccart-Gebhart, Martine
    Holmes, Eileen
    Baselga, Jose
    de Azambuja, Evandro
    Dueck, Amylou C.
    Viale, Giuseppe
    Zujewski, Jo Anne
    Goldhirsch, Aron
    Armour, Alison
    Pritchard, Kathleen I.
    McCullough, Ann E.
    Dolci, Stella
    McFadden, Eleanor
    Holmes, Andrew P.
    Liu Tonghua
    Eidtmann, Holger
    Phuong Dinh
    Di Cosimo, Serena
    Harbeck, Nadia
    Tjulandin, Sergei
    Im, Young-Hyuck
    Huang, Chiun-Sheng
    Dieras, Veronique
    Hillman, David W.
    Wolff, Antonio C.
    Jackisch, Christian
    Lang, Istvan
    Untch, Michael
    Smith, Ian
    Boyle, Frances
    Xu, Binghe
    Gomez, Henry
    Suter, Thomas
    Gelber, Richard D.
    Perez, Edith A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1034 - +
  • [19] Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials
    O'Sullivan, Ciara C.
    Bradbury, Ian
    Campbell, Christine
    Spielmann, Marc
    Perez, Edith A.
    Joensuu, Heikki
    Costantino, Joseph P.
    Delaloge, Suzette
    Rastogi, Priya
    Zardavas, Dimitrios
    Ballman, Karla V.
    Holmes, Eileen
    de Azambuja, Evandro
    Piccart-Gebhart, Martine
    Zujewski, Jo Anne
    Gelber, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2600 - U37
  • [20] Antibody-Drug Conjugates as an Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
    Asazuma, Kazuki
    Shimomura, Akihiko
    Shimizu, Chikako
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (18) : 2066 - +
12345